基于分区生存模型的帕博利珠单抗单药与化疗一线治疗PD-L1肿瘤比例分数不同的非小细胞肺癌的成本-效果分析
徐赫, 马爱霞
Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment in non-small cell lung cancer with different PD-L1 expression levels based on partitioned survival model
XU He, MA Ai-xia
中国医院药学杂志
.
2020, (23): 2468
-2473
.
DOI: 10.13286/j.1001-5213.2020.23.14
